Gene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophy
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
As more functional redundancy in mammalian cells is discovered, enhanced expression of genes involved in alternative pathways may become an effective form of gene therapy. X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder with impaired very-long-chain fatty acid metabolism. The X-ALD gene encodes a peroxisomal membrane protein (ALDP) that is part of a small family of related peroxisomal membrane proteins. We show that 4-phenylbutyrate treatment of cells from both X-ALD patients and X-ALD knockout mice results in decreased levels of and increased beta-oxidation of very-long-chain fatty acids; increased expression of the peroxisomal protein ALDRP; and induction of peroxisome proliferation. We also demonstrate that ALDP and ALDRP are functionally related, by ALDRP cDNA complementation of X-ALD fibroblasts. Finally, we demonstrate the in vivo efficacy of dietary 4-phenylbutyrate treatment through its production of a substantial reduction of very-long-chain fatty acid levels in the brain and adrenal glands of X-ALD mice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dietary treatment with 4PBA in ALD 2 mice has been shown to partially correct the accumulation of VLCFAs in brain and adrenal glands, correlating with ALDR protein induction and increased peroxisome proliferation (27).”
From Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy (2004) · cites this paper as [27]
In the citing paper
“Consistently, the residual peroxisomal β-oxidation of VLCFA is ~20% of normal in X-ALD fibroblasts [150,151] and can be restored by ABCD2 or ABCD3 overexpression [152,153].”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [153]
In the citing paper
“Overexpression of ALDRP cDNA in human and mouse X-ALD fibroblasts completely restores VLCFA β-oxidation and results in normal levels of VLCFAs [Kemp et al., 1998;Netik et al., 1999].”
From ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations (2001) · cites this paper as Kemp et al., 1998
In the citing paper
“The expression of the ABCD2 gene can be induced pharmacologically both in vitro and in vivo with 4-phenylbutyrate and fenofibrate [Kemp et al., 1998;Netik et al., 1999].”
From ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations (2001) · cites this paper as Kemp et al., 1998
In the citing paper
“increasing the expression of an alternate gene (ALDR, ABCD2), which can substitute, at least in part, for the function of ALDP (ABCD1) [Kemp et al., 1998]”
From ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations (2001) · cites this paper as Kemp et al., 1998
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,786
Annals of the New York Academy of Sciences
(2019) · Annals of the New York Academy of Sciences · doi:10.1111/(issn)1749-6632 · Cited by 1,305
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202
The metabolic basis of inherited disease
Goldstein, J. L. (1995) · Medical Entomology and Zoology · Cited by 1,009
Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene
Tinsley, J. M., Potter, A. C., Phelps, S. R., Fisher, R., Trickett, J. I., & Davies, K. E. (1996) · Nature · doi:10.1038/384349a0 · Cited by 490
Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy
Moser, H. (1997) · Brain · doi:10.1093/brain/120.8.1485 · Cited by 478
A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin Disorders
Perrine, S. P., Ginder, G. D., Faller, D. V., Dover, G. H., Ikuta, T., Witkowska, H. E., Cai, S.-P., Vichinsky, E. P., & Olivieri, N. F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280202 · Cited by 437
Kamijo, K., Taketani, S., Yokota, S., Osumi, T., & Hashimoto, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39595-x · Cited by 391
Rubenstein, R. C., Egan, M. E., & Zeitlin, P. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119788 · Cited by 389
Research works printed but not linked: 1
- Moser, H.W. & Moser, A.B. in Techniques in Diagnostic Biochemical Genetics: A Laboratory Manual (ed. A., H.F.) 177– 191 (Wiley-Liss, New York, 1991).
Cited by
Items 201–248 of 248
Metabolism of trideuterated iso‐lignoceric acid in rats in Vivo and in human fibroblasts in culture
Poulos, A., Stockham, P. C., Johnson, D. W., Paton, B. C., Beckman, K., & Singh, H. (1999) · Lipids · doi:10.1007/s11745-999-0444-y · Cited by 4
Ivan Petrovich Pavlov (1849-1936)
Haas, L. F. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.3.299 · Cited by 5
Bethin, K. E., & Muglia, L. J. (2013) · Humana Press eBooks · doi:10.1007/978-1-60761-395-4_12 · Cited by 4
Lessons from Knockout Mice II: Mouse Models for Peroxisomal Disorders with Single Protein Deficiency
Berger, J., Kunze, M., & Forss‐Petter, S. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9072-3_17 · Cited by 3
Almashanu, S., & Valle, D. L. (2003) · Elsevier eBooks · doi:10.1016/b978-012352551-2/50025-1 · Cited by 3
Induction and regulation of CAMP gene expression
Steinmann, J. (2009) · Skemman · Cited by 4
Therapy of X-linked adrenoleukodystrophy
Moser, H. W. (2006) · Neurotherapeutics · doi:10.1007/bf03207054 · Cited by 4
Marten, L. M., Lüttgens, M. S., Berečić, B., Tiburcy, M., Brüser, C., Gupta, S., Jakobs, S., Ammer, E., Ohlenbusch, A., Krätzner, R., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.10.289 · Cited by 4
Milanesi, A., & Brent, G. A. (2017) · Endocrinology · doi:10.1210/en.2017-00206 · Cited by 2
Molecular Complex Coordinating Peroxisome Morphogenesis in Mammalian Cells
Fujiki, Y., Itoyama, A., Abe, Y., & Honsho, M. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1788-0_17 · Cited by 2
Bethin, K. E., Majumdar, I., & Muglia, L. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-66296-6_10 · Cited by 2
Therapeutics of X-linked adrenoleukodystrophy
Eichler, F., & Aubourg, P. R. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2009.04.002 · Cited by 2
A Case of Adult-Onset Adrenoleukodystrophy Combined with Moyamoya Disease
Kim, Y., Park, B. H., Yu, T. Y., Jin, A. R., Noh, H. J., Yang, C. Y., Kim, H. Y., & Cho, C. G. (2009) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2009.24.1.58 · Cited by 2
Therapeutic Strategies for X-Linked Adrenoleukodystrophy, a Representative Peroxisomal Disorder
Morita, M. (2019) · Springer eBooks · doi:10.1007/978-981-15-1169-1_8 · Cited by 3
Adrenoleukodystrophy: Molecular, Metabolic, Pathologic, and Therapeutic Aspects
Contreras, M. A., & Singh, I. (2008) · Springer eBooks · doi:10.1007/978-0-387-30375-8_2 · Cited by 2
Gene Therapy of Adrenomyeloneuropathy: Challenges, Target Cells, and Prospectives
Bougneres, P. F., Stunff, C. L., & Badin, R. A. (2025) · Biomedicines · doi:10.3390/biomedicines13081892 · Cited by 1
Seizures: Balancing Fatty Acids in the Diet to Stabilize Brain Activity
Kane, P., & Cartaxo, A. (2009) · CRC Press eBooks · doi:10.1201/9781420067637.ch24 · Cited by 1
Neuromuscular Complications of General Medical Disorders
Ralph, J. W., & Aminoff, M. J. (2008) · Elsevier eBooks · doi:10.1016/b978-044306707-5.50063-8 · Cited by 3
Treatment: Present Status and New Trends
Walter, J. H., & Wraith, J. E. (2000) · Springer eBooks · doi:10.1007/978-3-662-04285-4_5 · Cited by 1
Bethin, K. E., Majumdar, I., & Muglia, L. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-73782-9_13 · Cited by 2
Garbern, J. Y. (2005) · Neurological disease and therapy · doi:10.1201/9780849358364.ch20 · Cited by 1
Endocrinology and systemic disease
James, R., Quinton, R., & BALL, S. D. (2002) · CRC Press eBooks · doi:10.1201/b15291-15 · Cited by 1
Di(2‐ethylhexyl)phthalate (DEHP) [MAK Value Documentation, 2009]
Arbeitsstoffe, D. F. S. S. Z. P. G., & Hartwig, A. (2012) · Wiley eBooks · doi:10.1002/3527600418.mb11781e0025 · Cited by 1
Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
Self-citationMoser, H. W., & van Geel, B. M. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545054.033
MacDonald, A. (2001) · Wiley eBooks · doi:10.1002/9780470690369.ch20
X-Linked Adrenoleukodystrophy/Adrenomyeloneuropathy
Rizzo, W. B. (2004) · Elsevier eBooks · doi:10.1016/b0-12-475570-4/00044-5
Nephrin : Intracellular trafficking and podocyte maturation
Doné, S. C. (2007) · Figshare
Molecular Genetics of Peroxisomal Disorders
Moser, H. W. (1998) · Fetal and Pediatric Pathology · doi:10.1080/15513819809168801
A happier sequel to Lorenzo's Oil?
Wanders, R. J. A. (1998) · Nature Medicine · doi:10.1038/3225
Molecular biology and pharmacogenetics of x-linked adrenoleukodystrophy
Kemp, S. (1999) · UvA-DARE (University of Amsterdam)
Self-citationThe metabolic profile of phenylbutyric acid and its antioxidant capacity in vervet monkeys
Linde, V. D. R. R., & Johanna, W. (2010)
X-Inaktivierung bei heterozygoten Überträgerinnen X-chromosomal gebundener Adrenoleukodystrophie
München, K. D. L.-M.-U., & Reinhardt, D. (2002)
Peña, S. O., & Barrera, A. (2005) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2
Neuromuscular Complications of General Medical Disorders
Ralph, J. W., & Aminoff, M. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407710-2.00059-x · Cited by 1
Auswirkungen des PPARγ-Agonisten Pioglitazon auf Peroxisomen des Gehirns im X-ALD-Mausmodell
Sinnig, K. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6336
Repurposing Clinic-Tested Drugs to Treat Rare Neurogenetic Diseases by Transcriptional Modulation
Hadwen, J. (2018) · uO Research (University of Ottawa) · doi:10.20381/ruor-21849
Wang, T., & Xie, Z. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7795-6_19
Baldwin, E., & MacDonald, A. (2007) · Wiley eBooks · doi:10.1002/9780470692004.ch21
Di(2‐ethylhexyl)phthalat (DEHP) [MAK Value Documentation in German language, 2002]
Arbeitsstoffe, D. F. S. S. Z. P. G., & Greim, H. (2012) · Wiley eBooks · doi:10.1002/3527600418.mb11781d0035
Moser, H. W. (2003) · Elsevier eBooks · doi:10.1016/b0-12-226870-9/00014-9
ADDRESSING CERAMIDE FORMATION IN ALS WITH PHOSPHOLIPID EMULSION AND PHENYLBUTYRATE
Kane, P. (2006) · Acupuncture & Electro-Therapeutics Research · doi:10.1177/036012932006031001009
ABNORMALITIES OF FATTY ACIDS IN TOXICITY AND NEUROLOGICAL DISORDERS
Kane, P. (2006) · Acupuncture & Electro-Therapeutics Research · doi:10.1177/036012932007032001005
ABNORMALITIES OF FATTY ACIDS IN TOXICITY AND NEUROLOGICAL DISORDERS
Kane, P. (2006) · Acupuncture & Electro-Therapeutics Research · doi:10.1177/036012932006031001007
Chapter 17 X-Linked Spastic Paraplegia
Garbern, J. Y. (2007) · Blue books of neurology · doi:10.1016/s1877-184x(09)70091-7
BindingDB (2024) · UC San Diego · doi:10.7270/q20v8j1b
Metadata
- Authors
- Kemp, S., Wei, H.-M., Lu, J.-F., Braiterman, L. T., McGuinness, M. C., Moser, A. B., Watkins, P. A., & Smith, K. D.
- Affiliations
- Kennedy Krieger Institute (US)
- Corresponding author
- Smith, Kirby D.
- Venue
- Nature Medicine
- Published
- 1998-11
- Volume
- 4
- Issue
- 11
- Pages
- 1261-1268
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- DOI
- 10.1038/3242
- OpenAlex
- W2035026471
- Cited by
- 249
- References
- 57
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 6 · 2020: 3 · 2019: 3 · 2018: 7 · 2017: 5 · 2016: 5 · 2015: 4 · 2014: 7 · 2013: 12 · 2012: 7
- FWCI
- 13.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- National Institutes of Health (1r01dk051149-01)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK51149)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD24061, HD-10981, P30HD024061, P01HD010981)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- X-linked adrenoleukodystrophy, gene redundancy, 4-phenylbutyric acid, peroxisomal membrane proteins, ALDP, very long chain fatty acids, fatty acid beta-oxidation, peroxisome proliferation, peroxisomal disorders, dietary therapy
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily D, ATP Binding Cassette Transporter, Subfamily D, Member 1, Adrenoleukodystrophy, Animals, Cell Line, Cells, Cultured, Fibroblasts, Multigene Family, Humans, Lymphocytes, Microbodies, Phenylbutyrates, Proteins, X Chromosome, Genetic Therapy, DNA Primers, Mice, Knockout, ATP-Binding Cassette Transporters, Reverse Transcriptase Polymerase Chain Reaction, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.